DrugBank ID: db05259
Synonymous :(t,g)-a-l | cop 1 | cop-1 | copolymer i (synthetic peptide) | copolymer-1
Drug Sentece Context
Table 1. Analysis of context sentence of glatiramer gene in 3 abstracts.
|32477373||Considering the immunological responses against infections with novel coronaviruses in humans, interferons, glatiramer acetate, and teriflunomide appear to be safe.|
|32609290||We focus on how to 1) reduce COVID-19 infection risk, such as social distancing, telemedicine, and wider interval between laboratory testing/imaging; 2) manage relapses, such as avoiding treatment of mild relapse and using oral steroids; 3) manage disease-modifying therapies, such as preference for drugs associated with lower infection risk (interferons, glatiramer, teriflunomide, and natalizumab) and extended-interval dosing of natalizumab, when safe; 4) individualize the chosen MS induction-therapy (anti-CD20 monoclonal antibodies, alemtuzumab, and cladribine); 5) manage NMOSD preventive therapies, including initial therapy selection and current treatment maintenance; 6) manage MS/NMOSD patients infected with COVID-19.|
|32769063||Vaccine responses were reduced to varying degrees in those treated with glatiramer acetate, teriflunomide, sphingosine-1-phosphate receptor modulators, and natalizumab.|
|33388661||Two patients were treated with dimethyl fumarate, one with Interferon β1b and one with glatiramer acetate.|